1 Market Overview of Activated Partial Thromboplastin Test 1.1 Activated Partial Thromboplastin Test Market Overview 1.1.1 Activated Partial Thromboplastin Test Product Scope 1.1.2 Activated Partial Thromboplastin Test Market Status and Outlook 1.2 Global Activated Partial Thromboplastin Test Market Size Overview by Region 2016 VS 2021VS 2027 1.3 Global Activated Partial Thromboplastin Test Market Size by Region (2016-2027) 1.4 Global Activated Partial Thromboplastin Test Historic Market Size by Region (2016-2021) 1.5 Global Activated Partial Thromboplastin Test Market Size Forecast by Region (2022-2027) 1.6 Key Regions, Activated Partial Thromboplastin Test Market Size (2016-2027) 1.6.1 North America Activated Partial Thromboplastin Test Market Size (2016-2027) 1.6.2 Europe Activated Partial Thromboplastin Test Market Size (2016-2027) 1.6.3 Asia-Pacific Activated Partial Thromboplastin Test Market Size (2016-2027) 1.6.4 Latin America Activated Partial Thromboplastin Test Market Size (2016-2027) 1.6.5 Middle East & Africa Activated Partial Thromboplastin Test Market Size (2016-2027) 2 Activated Partial Thromboplastin Test Market Overview by Type 2.1 Global Activated Partial Thromboplastin Test Market Size by Type: 2016 VS 2021 VS 2027 2.2 Global Activated Partial Thromboplastin Test Historic Market Size by Type (2016-2021) 2.3 Global Activated Partial Thromboplastin Test Forecasted Market Size by Type (2022-2027) 2.4 Optical Technology Test 2.5 Mechanical Technology Test 2.6 Electrochemical Technology Test 3 Activated Partial Thromboplastin Test Market Overview by Application 3.1 Global Activated Partial Thromboplastin Test Market Size by Application: 2016 VS 2021 VS 2027 3.2 Global Activated Partial Thromboplastin Test Historic Market Size by Application (2016-2021) 3.3 Global Activated Partial Thromboplastin Test Forecasted Market Size by Application (2022-2027) 3.4 Hospital 3.5 Clinic 3.6 Others 4 Activated Partial Thromboplastin Test Competition Analysis by Players 4.1 Global Activated Partial Thromboplastin Test Market Size by Players (2016-2021) 4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Activated Partial Thromboplastin Test as of 2020) 4.3 Date of Key Players Enter into Activated Partial Thromboplastin Test Market 4.4 Global Top Players Activated Partial Thromboplastin Test Headquarters and Area Served 4.5 Key Players Activated Partial Thromboplastin Test Product Solution and Service 4.6 Competitive Status 4.6.1 Activated Partial Thromboplastin Test Market Concentration Rate 4.6.2 Mergers & Acquisitions, Expansion Plans 5 Company (Top Players) Profiles and Key Data 5.1 Horiba 5.1.1 Horiba Profile 5.1.2 Horiba Main Business 5.1.3 Horiba Activated Partial Thromboplastin Test Products, Services and Solutions 5.1.4 Horiba Activated Partial Thromboplastin Test Revenue (US$ Million) & (2016-2021) 5.1.5 Horiba Recent Developments 5.2 Bio-Rad 5.2.1 Bio-Rad Profile 5.2.2 Bio-Rad Main Business 5.2.3 Bio-Rad Activated Partial Thromboplastin Test Products, Services and Solutions 5.2.4 Bio-Rad Activated Partial Thromboplastin Test Revenue (US$ Million) & (2016-2021) 5.2.5 Bio-Rad Recent Developments 5.3 Takara Bio 5.5.1 Takara Bio Profile 5.3.2 Takara Bio Main Business 5.3.3 Takara Bio Activated Partial Thromboplastin Test Products, Services and Solutions 5.3.4 Takara Bio Activated Partial Thromboplastin Test Revenue (US$ Million) & (2016-2021) 5.3.5 Johnson & Johnson Recent Developments 5.4 Johnson & Johnson 5.4.1 Johnson & Johnson Profile 5.4.2 Johnson & Johnson Main Business 5.4.3 Johnson & Johnson Activated Partial Thromboplastin Test Products, Services and Solutions 5.4.4 Johnson & Johnson Activated Partial Thromboplastin Test Revenue (US$ Million) & (2016-2021) 5.4.5 Johnson & Johnson Recent Developments 5.5 Siemens 5.5.1 Siemens Profile 5.5.2 Siemens Main Business 5.5.3 Siemens Activated Partial Thromboplastin Test Products, Services and Solutions 5.5.4 Siemens Activated Partial Thromboplastin Test Revenue (US$ Million) & (2016-2021) 5.5.5 Siemens Recent Developments 5.6 Abbott 5.6.1 Abbott Profile 5.6.2 Abbott Main Business 5.6.3 Abbott Activated Partial Thromboplastin Test Products, Services and Solutions 5.6.4 Abbott Activated Partial Thromboplastin Test Revenue (US$ Million) & (2016-2021) 5.6.5 Abbott Recent Developments 5.7 BioMeriux 5.7.1 BioMeriux Profile 5.7.2 BioMeriux Main Business 5.7.3 BioMeriux Activated Partial Thromboplastin Test Products, Services and Solutions 5.7.4 BioMeriux Activated Partial Thromboplastin Test Revenue (US$ Million) & (2016-2021) 5.7.5 BioMeriux Recent Developments 5.8 Thermo Fisher Scientific 5.8.1 Thermo Fisher Scientific Profile 5.8.2 Thermo Fisher Scientific Main Business 5.8.3 Thermo Fisher Scientific Activated Partial Thromboplastin Test Products, Services and Solutions 5.8.4 Thermo Fisher Scientific Activated Partial Thromboplastin Test Revenue (US$ Million) & (2016-2021) 5.8.5 Thermo Fisher Scientific Recent Developments 5.9 Danaher 5.9.1 Danaher Profile 5.9.2 Danaher Main Business 5.9.3 Danaher Activated Partial Thromboplastin Test Products, Services and Solutions 5.9.4 Danaher Activated Partial Thromboplastin Test Revenue (US$ Million) & (2016-2021) 5.9.5 Danaher Recent Developments 5.10 Carlyle Group 5.10.1 Carlyle Group Profile 5.10.2 Carlyle Group Main Business 5.10.3 Carlyle Group Activated Partial Thromboplastin Test Products, Services and Solutions 5.10.4 Carlyle Group Activated Partial Thromboplastin Test Revenue (US$ Million) & (2016-2021) 5.10.5 Carlyle Group Recent Developments 5.11 BD 5.11.1 BD Profile 5.11.2 BD Main Business 5.11.3 BD Activated Partial Thromboplastin Test Products, Services and Solutions 5.11.4 BD Activated Partial Thromboplastin Test Revenue (US$ Million) & (2016-2021) 5.11.5 BD Recent Developments 5.12 Roche 5.12.1 Roche Profile 5.12.2 Roche Main Business 5.12.3 Roche Activated Partial Thromboplastin Test Products, Services and Solutions 5.12.4 Roche Activated Partial Thromboplastin Test Revenue (US$ Million) & (2016-2021) 5.12.5 Roche Recent Developments 6 North America 6.1 North America Activated Partial Thromboplastin Test Market Size by Country (2016-2027) 6.2 United States 6.3 Canada 7 Europe 7.1 Europe Activated Partial Thromboplastin Test Market Size by Country (2016-2027) 7.2 Germany 7.3 France 7.4 U.K. 7.5 Italy 7.6 Russia 7.7 Nordic 7.8 Rest of Europe 8 Asia-Pacific 8.1 Asia-Pacific Activated Partial Thromboplastin Test Market Size by Region (2016-2027) 8.2 China 8.3 Japan 8.4 South Korea 8.5 Southeast Asia 8.6 India 8.7 Australia 8.8 Rest of Asia-Pacific 9 Latin America 9.1 Latin America Activated Partial Thromboplastin Test Market Size by Country (2016-2027) 9.2 Mexico 9.3 Brazil 9.4 Rest of Latin America 10 Middle East & Africa 10.1 Middle East & Africa Activated Partial Thromboplastin Test Market Size by Country (2016-2027) 10.2 Turkey 10.3 Saudi Arabia 10.4 UAE 10.5 Rest of Middle East & Africa 11 Activated Partial Thromboplastin Test Market Dynamics 11.1 Activated Partial Thromboplastin Test Industry Trends 11.2 Activated Partial Thromboplastin Test Market Drivers 11.3 Activated Partial Thromboplastin Test Market Challenges 11.4 Activated Partial Thromboplastin Test Market Restraints 12 Research Finding /Conclusion 13 Methodology and Data Source 13.1 Methodology/Research Approach 13.1.1 Research Programs/Design 13.1.2 Market Size Estimation 13.1.3 Market Breakdown and Data Triangulation 13.2 Data Source 13.2.1 Secondary Sources 13.2.2 Primary Sources 13.3 Disclaimer 13.4 Author List

List of Tables Table 1. Global Market Activated Partial Thromboplastin Test Market Size (US$ Million) Comparison by Region 2016 VS 2021 VS 2027 Table 2. Global Activated Partial Thromboplastin Test Market Size by Region (2016-2021) & (US$ Million) Table 3. Global Activated Partial Thromboplastin Test Market Size Share by Region (2016-2021) Table 4. Global Activated Partial Thromboplastin Test Forecasted Market Size by Region (2022-2027) & (US$ Million) Table 5. Global Activated Partial Thromboplastin Test Forecasted Market Size Share by Region (2022-2027) Table 6. Global Activated Partial Thromboplastin Test Market Size (US$ Million) by Type: 2016 VS 2021 VS 2027 Table 7. Global Activated Partial Thromboplastin Test Market Size by Type (2016-2021) & (US$ Million) Table 8. Global Activated Partial Thromboplastin Test Revenue Market Share by Type (2016-2021) Table 9. Global Activated Partial Thromboplastin Test Forecasted Market Size by Type (2022-2027) & (US$ Million) Table 10. Global Activated Partial Thromboplastin Test Revenue Market Share by Type (2022-2027) Table 11. Global Activated Partial Thromboplastin Test Market Size (US$ Million) by Application: 2016 VS 2021 VS 2027 Table 12. Global Activated Partial Thromboplastin Test Market Size by Application (2016-2021) & (US$ Million) Table 13. Global Activated Partial Thromboplastin Test Revenue Market Share by Application (2016-2021) Table 14. Global Activated Partial Thromboplastin Test Forecasted Market Size by Application (2022-2027) & (US$ Million) Table 15. Global Activated Partial Thromboplastin Test Revenue Market Share by Application (2022-2027) Table 16. Global Activated Partial Thromboplastin Test Revenue (US$ Million) by Players (2016-2021) Table 17. Global Activated Partial Thromboplastin Test Revenue Market Share by Players (2016-2021) Table 18. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Activated Partial Thromboplastin Test as of 2020) Table 19. Date of Key Manufacturers Enter into Activated Partial Thromboplastin Test Market Table 20. Global Activated Partial Thromboplastin Test Top Players Headquarters and Area Served Table 21. Activated Partial Thromboplastin Test Product Solution and Service Table 22. Global Activated Partial Thromboplastin Test Players Market Concentration Ratio (CR5 and HHI) Table 23. Mergers & Acquisitions, Expansion Plans Table 24. Horiba Basic Information List Table 25. Horiba Description and Business Overview Table 26. Horiba Activated Partial Thromboplastin Test Products, Services and Solutions Table 27. Revenue (US$ Million) in Activated Partial Thromboplastin Test Business of Horiba (2016-2021) Table 28. Horiba Recent Developments Table 29. Bio-Rad Basic Information List Table 30. Bio-Rad Description and Business Overview Table 31. Bio-Rad Activated Partial Thromboplastin Test Products, Services and Solutions Table 32. Revenue (US$ Million) in Activated Partial Thromboplastin Test Business of Bio-Rad (2016-2021) Table 33. Bio-Rad Recent Developments Table 34. Takara Bio Basic Information List Table 35. Takara Bio Description and Business Overview Table 36. Takara Bio Activated Partial Thromboplastin Test Products, Services and Solutions Table 37. Revenue (US$ Million) in Activated Partial Thromboplastin Test Business of Takara Bio (2016-2021) Table 38. Takara Bio Recent Developments Table 39. Johnson & Johnson Basic Information List Table 40. Johnson & Johnson Description and Business Overview Table 41. Johnson & Johnson Activated Partial Thromboplastin Test Products, Services and Solutions Table 42. Revenue (US$ Million) in Activated Partial Thromboplastin Test Business of Johnson & Johnson (2016-2021) Table 43. Johnson & Johnson Recent Developments Table 44. Siemens Basic Information List Table 45. Siemens Description and Business Overview Table 46. Siemens Activated Partial Thromboplastin Test Products, Services and Solutions Table 47. Revenue (US$ Million) in Activated Partial Thromboplastin Test Business of Siemens (2016-2021) Table 48. Siemens Recent Developments Table 49. Abbott Basic Information List Table 50. Abbott Description and Business Overview Table 51. Abbott Activated Partial Thromboplastin Test Products, Services and Solutions Table 52. Revenue (US$ Million) in Activated Partial Thromboplastin Test Business of Abbott (2016-2021) Table 53. Abbott Recent Developments Table 54. BioMeriux Basic Information List Table 55. BioMeriux Description and Business Overview Table 56. BioMeriux Activated Partial Thromboplastin Test Products, Services and Solutions Table 57. Revenue (US$ Million) in Activated Partial Thromboplastin Test Business of BioMeriux (2016-2021) Table 58. BioMeriux Recent Developments Table 59. Thermo Fisher Scientific Basic Information List Table 60. Thermo Fisher Scientific Description and Business Overview Table 61. Thermo Fisher Scientific Activated Partial Thromboplastin Test Products, Services and Solutions Table 62. Revenue (US$ Million) in Activated Partial Thromboplastin Test Business of Thermo Fisher Scientific (2016-2021) Table 63. Thermo Fisher Scientific Recent Developments Table 64. Danaher Basic Information List Table 65. Danaher Description and Business Overview Table 66. Danaher Activated Partial Thromboplastin Test Products, Services and Solutions Table 67. Revenue (US$ Million) in Activated Partial Thromboplastin Test Business of Danaher (2016-2021) Table 68. Danaher Recent Developments Table 69. Carlyle Group Basic Information List Table 70. Carlyle Group Description and Business Overview Table 71. Carlyle Group Activated Partial Thromboplastin Test Products, Services and Solutions Table 72. Revenue (US$ Million) in Activated Partial Thromboplastin Test Business of Carlyle Group (2016-2021) Table 73. Carlyle Group Recent Developments Table 74. BD Basic Information List Table 75. BD Description and Business Overview Table 76. BD Activated Partial Thromboplastin Test Products, Services and Solutions Table 77. Revenue (US$ Million) in Activated Partial Thromboplastin Test Business of BD (2016-2021) Table 78. BD Recent Developments Table 79. Roche Basic Information List Table 80. Roche Description and Business Overview Table 81. Roche Activated Partial Thromboplastin Test Products, Services and Solutions Table 82. Revenue (US$ Million) in Activated Partial Thromboplastin Test Business of Roche (2016-2021) Table 83. Roche Recent Developments Table 84. North America Activated Partial Thromboplastin Test Market Size by Country (2016-2021) & (US$ Million) Table 85. North America Activated Partial Thromboplastin Test Market Size by Country (2022-2027) & (US$ Million) Table 86. Europe Activated Partial Thromboplastin Test Market Size by Country (2016-2021) & (US$ Million) Table 87. Europe Activated Partial Thromboplastin Test Market Size by Country (2022-2027) & (US$ Million) Table 88. Asia-Pacific Activated Partial Thromboplastin Test Market Size by Region (2016-2021) & (US$ Million) Table 89. Asia-Pacific Activated Partial Thromboplastin Test Market Size by Region (2022-2027) & (US$ Million) Table 90. Asia-Pacific Activated Partial Thromboplastin Test Market Share by Region (2016-2021) Table 91. Asia-Pacific Activated Partial Thromboplastin Test Market Share by Region (2022-2027) Table 92. Latin America Activated Partial Thromboplastin Test Market Size by Country (2016-2021) & (US$ Million) Table 93. Latin America Activated Partial Thromboplastin Test Market Size by Country (2022-2027) & (US$ Million) Table 94. Middle East & Africa Activated Partial Thromboplastin Test Market Size by Players (2016-2021) & (US$ Million) Table 95. Middle East & Africa Activated Partial Thromboplastin Test Market Size by Country (2022-2027) & (US$ Million) Table 96. Activated Partial Thromboplastin Test Market Trends Table 97. Activated Partial Thromboplastin Test Market Drivers Table 98. Activated Partial Thromboplastin Test Market Challenges Table 99. Activated Partial Thromboplastin Test Market Restraints Table 100. Research Programs/Design for This Report Table 101. Key Data Information from Secondary Sources Table 102. Key Data Information from Primary Sources List of Figures Figure 1. Global Activated Partial Thromboplastin Test Market Size Year-over-Year 2016-2027 & (US$ Million) Figure 2. Global Activated Partial Thromboplastin Test Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 3. Global Activated Partial Thromboplastin Test Market Share by Regions: 2021 VS 2027 Figure 4. Global Activated Partial Thromboplastin Test Forecasted Market Size Share by Region (2022-2027) Figure 5. North America Activated Partial Thromboplastin Test Market Size (US$ Million) Growth Rate (2016-2027) Figure 6. Europe Activated Partial Thromboplastin Test Market Size (US$ Million) and Growth Rate (2016-2027) Figure 7. Asia-Pacific Activated Partial Thromboplastin Test Market Size (US$ Million) and Growth Rate (2016-2027) Figure 8. Latin America Activated Partial Thromboplastin Test Market Size (US$ Million) and Growth Rate (2016-2027) Figure 9. Middle East & Africa Activated Partial Thromboplastin Test Market Size (US$ Million) and Growth Rate (2016-2027) Figure 10. Global Activated Partial Thromboplastin Test Market Size Share by Type in 2021 & 2027 Figure 11. Optical Technology Test Market Size (US$ Million) YoY Growth (2016-2027) Figure 12. Mechanical Technology Test Market Size (US$ Million) YoY Growth (2016-2027) Figure 13. Electrochemical Technology Test Market Size (US$ Million) YoY Growth (2016-2027) Figure 14. Global Activated Partial Thromboplastin Test Market Size Share by Application in 2021 & 2027 Figure 15. Hospital Market Size (US$ Million) YoY Growth (2016-2027) Figure 16. Clinic Market Size (US$ Million) YoY Growth (2016-2027) Figure 17. Others Market Size (US$ Million) YoY Growth (2016-2027) Figure 18. Activated Partial Thromboplastin Test Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020 Figure 19. Global Top 5 and Top 10 Players Activated Partial Thromboplastin Test Market Share in 2020 Figure 20. North America Activated Partial Thromboplastin Test Market Share by Country (2016-2027) Figure 21. United States Activated Partial Thromboplastin Test Market Size (2016-2027) & (US$ Million) Figure 22. Canada Activated Partial Thromboplastin Test Market Size (2016-2027) & (US$ Million) Figure 23. Germany Activated Partial Thromboplastin Test Market Size (2016-2027) & (US$ Million) Figure 24. France Activated Partial Thromboplastin Test Market Size (2016-2027) & (US$ Million) Figure 25. U.K. Activated Partial Thromboplastin Test Market Size (2016-2027) & (US$ Million) Figure 26. Italy Activated Partial Thromboplastin Test Market Size (2016-2027) & (US$ Million) Figure 27. Russia Activated Partial Thromboplastin Test Market Size (2016-2027) & (US$ Million) Figure 28. Nordic Activated Partial Thromboplastin Test Market Size (2016-2027) & (US$ Million) Figure 29. Rest of Europe Activated Partial Thromboplastin Test Market Size (2016-2027) & (US$ Million) Figure 30. Asia-Pacific Activated Partial Thromboplastin Test Market Share by Region (2016-2027) Figure 31. China Activated Partial Thromboplastin Test Market Size (2016-2027) & (US$ Million) Figure 32. Japan Activated Partial Thromboplastin Test Market Size (2016-2027) & (US$ Million) Figure 33. South Korea Activated Partial Thromboplastin Test Market Size (2016-2027) & (US$ Million) Figure 34. Southeast Asia Activated Partial Thromboplastin Test Market Size (2016-2027) & (US$ Million) Figure 35. India Activated Partial Thromboplastin Test Market Size (2016-2027) & (US$ Million) Figure 36. Australia Activated Partial Thromboplastin Test Market Size (2016-2027) & (US$ Million) Figure 37. Rest of Asia-Pacific Activated Partial Thromboplastin Test Market Size (2016-2027) & (US$ Million) Figure 38. Latin America Activated Partial Thromboplastin Test Market Share by Country (2016-2027) Figure 39. Mexico Activated Partial Thromboplastin Test Market Size (2016-2027) & (US$ Million) Figure 40. Brazil Activated Partial Thromboplastin Test Market Size (2016-2027) & (US$ Million) Figure 41. Rest of Latin America Activated Partial Thromboplastin Test Market Size (2016-2027) & (US$ Million) Figure 42. Middle East & Africa Activated Partial Thromboplastin Test Market Share by Country (2016-2027) Figure 43. Turkey Activated Partial Thromboplastin Test Market Size (2016-2027) & (US$ Million) Figure 44. Saudi Arabia Activated Partial Thromboplastin Test Market Size (2016-2027) & (US$ Million) Figure 45. UAE Activated Partial Thromboplastin Test Market Size (2016-2027) & (US$ Million) Figure 46. Rest of Middle East & Africa Activated Partial Thromboplastin Test Market Size (2016-2027) & (US$ Million) Figure 47. Bottom-up and Top-down Approaches for This Report Figure 48. Data Triangulation

Horiba Bio-Rad Takara Bio Johnson & Johnson Siemens Abbott BioMeriux Thermo Fisher Scientific Danaher Carlyle Group BD Roche